Skip to content
Clinical Trial Events
ISPOR Europe 2026

Panel Real-World Evidence (RWE) track

From Static to Dynamic Value: Can Living HTA and AI Reshape the Innovation Cycle?

Wed, Nov 11, 2026 · 8:00–9:00 AM CET Hall D, Level -2, Austria Center Vienna

About this session

ISSUE: Health Technology Assessment (HTA) has traditionally been conducted as static, one-off value assessments at launch, which can become outdated as evidence evolves. This panel will explore the emergence of living HTA, where conditional reimbursement is linked to RWE-driven reassessment to enable earlier patient access while managing uncertainty.

Speakers